November 2, 2018 — Janssen Pharmaceuticals, Inc. has initiated a voluntary recall of one lot of Ortho-Novum® 1/35 (norethindrone/ethinyl estradiol) Tablets and two lots of Ortho-Novum® 7/7/7 (norethindrone/ethinyl estradiol) Tablets to the pharmacy level. The patient information provided inside affected packages of Ortho-Novum® does not include the appropriate instructions for the Veridate® dispenser.
top of page
CHEARS
Search
Recent Posts
See AllToday, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate...
bottom of page
Comments